Contract 36C25521N0140
New York Blood Center, Inc. · Department Of Veterans Affairs · October 1, 2020
New York Blood Center, Inc. was awarded a federal contract by Department Of Veterans Affairs on October 1, 2020 for $570,000 of work in biological product (except diagnostic) manufacturing. Performance is in Kansas City, MO. This is a task or delivery order issued under parent IDIQ VA25516D0217. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on October 31, 2022.
Contract details
- PIID
- 36C25521N0140
- Parent IDIQ
- VA25516D0217
- Award type
- Delivery Order
- Pricing
- Fixed Price With Economic Price Adjustment
- Competition
- Full And Open Competition
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- Place of performance
- Kansas City, MO
- First action
- October 1, 2020
- Latest action
- October 31, 2022
Description
BLOOD AND BLOOD PRODUCTS FOR KANSAS CITY, LEAVENWORTH AND TOPEKA VA MEDICAL CENTERS.
Modification timeline
-
October 31, 2022Mod P00002$4.5K
-
April 15, 2022Mod P00001$-114.2K
-
October 1, 2020Base award$680.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| American National Red Cross, The | Department Of Veterans Affairs | March 25, 2026 | $1.65M |
| New York Blood Center, Inc. | Department Of Veterans Affairs | March 18, 2026 | $670.0K |
| Binding Site, Inc., The | Department Of Veterans Affairs | March 18, 2026 | $137.6K |
| Binding Site, Inc., The | Department Of Veterans Affairs | March 18, 2026 | $102.8K |
| Binding Site, Inc., The | Department Of Veterans Affairs | March 18, 2026 | $124.6K |
| Binding Site, Inc., The | Department Of Veterans Affairs | March 18, 2026 | $0 |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C25521N0140?
Contract 36C25521N0140 is a federal contract awarded to New York Blood Center, Inc. by Department Of Veterans Affairs on October 1, 2020 for $570,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 36C25521N0140?
New York Blood Center, Inc. won contract 36C25521N0140 from Department Of Veterans Affairs.
How much is contract 36C25521N0140 worth?
Contract 36C25521N0140 has obligated $570,000 to date.